Scripps' 2019 ASCO Update on Advanced Urothelial Cancer: First-Line Bevacizumab, Maintenance Pembro Effect on PFS, New Data on the Use of Enfortumab Vedotin

351 views
August 30, 2019
0 Comments
Login to view comments. Click here to Login